Darvocet and Darvon Withdrawn from U.S. Market Due to Risk of Abnormal Heart Activity
The drug propoxyphone marketed and sold as Darvocet and Darvon was recently withdrawn from the U.S. market by its manufacturer, Xanodyne Pharmaceuticals, at the request of the U.S. Food and Drug Administration (FDA). The drug, which is an opioid pain reliever used to treat mild to moderate pain, was originally approved by the FDA more […]